Advertisement
Advertisement

NVS

NVS logo

Novartis AG

153.81
USD
Sponsored
-0.84
-0.54%
Aug 28, 16:00 UTC -4
Closed
exchange

After-Market

153.40

-0.41
-0.27%

NVS Earnings Reports

Positive Surprise Ratio

NVS beat 25 of 42 last estimates.

60%

Next Report

Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$14.86B
/
$2.28
Implied change from Q2 26 (Revenue/ EPS)
+3.13%
/
-5.39%
Implied change from Q3 25 (Revenue/ EPS)
+6.83%
/
+1.33%

Novartis AG earnings per share and revenue

On Jul 21, 2026, NVS reported earnings of 2.41 USD per share (EPS) for Q2 26, beating the estimate of 2.31 USD, resulting in a 4.23% surprise. Revenue reached 14.41 billion, compared to an expected 14.60 billion, with a -1.33% difference. The market reacted with a +2.88% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 2.28 USD, with revenue projected to reach 14.86 billion USD, implying an decrease of -5.39% EPS, and increase of 3.13% in Revenue from the last quarter.
FAQ
For Q2 2026, Novartis AG reported EPS of $2.41, beating estimates by 4.23%, and revenue of $14.41B, -1.33% below expectations.
The stock price moved up 2.88%, changed from $149.56 before the earnings release to $153.87 the day after.
The next earning report is scheduled for Oct 27, 2026.
Based on 4 analysts, Novartis AG is expected to report EPS of $2.28 and revenue of $14.86B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement